786 related articles for article (PubMed ID: 21334391)
1. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
[TBL] [Abstract][Full Text] [Related]
2. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
3. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
[TBL] [Abstract][Full Text] [Related]
4. MAPPIT analysis of early Toll-like receptor signalling events.
Ulrichts P; Tavernier J
Immunol Lett; 2008 Mar; 116(2):141-8. PubMed ID: 18221795
[TBL] [Abstract][Full Text] [Related]
5. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
7. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors and adaptor molecules in liver disease: update.
Seki E; Brenner DA
Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
[TBL] [Abstract][Full Text] [Related]
9. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
[TBL] [Abstract][Full Text] [Related]
10. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
11. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
Downer EJ; Johnston DG; Lynch MA
Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
[TBL] [Abstract][Full Text] [Related]
12. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
Lee SM; Kim EJ; Suk K; Lee WH
J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
[TBL] [Abstract][Full Text] [Related]
14. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
16. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
18. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
[TBL] [Abstract][Full Text] [Related]
20. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]